Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cell therapy
Biotech
Kadimastem gets shareholder backing for NLS merger
Kadimastem shareholders signing off on a merger with NLS that would enable the cell therapy developer to recover from last year’s thwarted attempt.
Nick Paul Taylor
Jan 31, 2025 9:42am
Cell therapy biotech Aurion joins IPO surge
Jan 27, 2025 2:42pm
Bristol Myers culls cell therapy deals with 2 biotechs
Dec 16, 2024 11:19am
Carisma axes sole clinical candidate, lays off 34% of staff
Dec 9, 2024 10:58am
Protara shares spike after bladder cancer data drop
Dec 5, 2024 2:30pm
Novartis taps Vyriad’s viral vectors for in vivo T cell editing
Nov 20, 2024 12:00pm